Novartis India Ltd - 500672 - Shareholding for the Period Ended September 30, 2021
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here19-10-2021
19-10-2021
NOVARTIS INDIA LTD. - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The certificate dated October 5, 2021, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms of the provisions of Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2021, is enclosed herewith for your records.11-10-2021
NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer08-10-2021
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the shareholders have lost their share certificates, as per the information received from the Company's Registrar and Share Transfer Agent on October 05, 2021 and October 06, 2021, as detailed in the attachment. Request you to take the same on record.06-10-2021
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you regarding issue of duplicate share certificate(s) to the shareholders of the Company on September 30, 2021, as per the information received from the Company's Registrar and Share Transfer Agent on September 29, 2021, as detailed in the attachment.30-09-2021
NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Considering The Unaudited Financial Results Of The Company For The Second Quarter Ending On September 30, 2021
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the second quarter ending on September 30, 2021.30-09-2021
NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window
Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 11, 2021, to inter alia consider the Unaudited financial results of the Company for the second quarter ending on September 30, 2021 ("said results"). In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Friday, October 1, 2021 to Saturday, November 13, 2021 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in.30-09-2021
Novartis buys gene therapy firm Arctos Medical to boost vision loss treatment
Arctos's technology is a potential way to treat inherited retinal dystrophies (IRDs) and other diseases that involve photoreceptor loss, such as age-related macular degeneration (AMD)21-09-2021
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on September 9, 2021, as mentioned in an attachment. Request you to take the same on record as required under the provisions of the said Regulation.13-09-2021
Novartis India Ltd - 500672 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Novartis India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here28-08-2021